Peanut allergy breakthrough? new study tests daily dosing to build tolerance in kids
NCT ID NCT07592780
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether giving children with peanut allergy small, increasing amounts of peanut protein (oral immunotherapy) can help them tolerate more peanut without a reaction. It compares this approach to the standard care of strictly avoiding peanuts. The goal is to see if this treatment works in real-world settings and to find out which children benefit most. About 125 children aged 2 to 17 with confirmed peanut allergy will take part.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FOOD ALLERGY IN CHILDREN are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Department of Paediatrics, Prince of Wales Hospital
RECRUITINGHong Kong, Hong Kong
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a Mother's diet during pregnancy prevent peanut and egg allergies in her baby?
- Fish allergy cure? new trial tests codfish therapy in kids
- Boiled cashews could be key to taming cashew allergies in kids
- Study reveals growth patterns in kids with food allergies
- New digital tool aims to slash peanut allergy rates in infants
- Fast vs. slow: which oral allergy treatment works best for kids?